e-learning
resources
Copenhagen 2005
Monday 19.09.2005
Clinical and diagnostic features in tuberculosis I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Skin test reactivity in non HIV pediatric patients exposed to TB active lung disease. Predictor of active disease
M. L. Boza, C. Pena, F. Prado, H. Barrientos, Z. Torres (Santiago, Chile)
Source:
Annual Congress 2005 - Clinical and diagnostic features in tuberculosis I
Session:
Clinical and diagnostic features in tuberculosis I
Session type:
Thematic Poster Session
Number:
2632
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. L. Boza, C. Pena, F. Prado, H. Barrientos, Z. Torres (Santiago, Chile). Skin test reactivity in non HIV pediatric patients exposed to TB active lung disease. Predictor of active disease. Eur Respir J 2005; 26: Suppl. 49, 2632
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
Performance and post-treatment conversion of latent tuberculosis test (QUANTIFERON) in immunocompromised patients with neoplasmatic disease
Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Year: 2010
New skin test with recombinant protein CFP10-ESAT6 in patients (children and adults) with tuberculosis, non-tuberculosis disease and latent TB infection
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012
Does the clinical symptoms of drug resistant pulmonary tuberculosis (PTB) act as a predictor in HIV non-infected/infected patient? An Indian scenario
Source: Eur Respir J 2006; 28: Suppl. 50, 858s
Year: 2006
Sensitivity and specificity of new skin test with recombinant protein CFP10-ESAT6 in patients with tuberculosis and individuals with non- tuberculosis diseases
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013
Clinical characteristics and treatment response of pulmonary cryptococcosis in HIV negative patients
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009
Lymphopenia as a mortality predictor in non HIV pulmonary TB patients
Source: Eur Respir J 2004; 24: Suppl. 48, 424s
Year: 2004
Diagnosis of latent tuberculosis infection in patients with chronic liver disease undergoing liver transplantation: performance of the new IFN-γ-based assays
Source: Eur Respir J 2007; 30: Suppl. 51, 752s
Year: 2007
Comparison of effector T-cell responses in patients with active TB disease compared to latent TB infection
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007
Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011
Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands
Source: Eur Respir J 2016; 48: 1420-1428
Year: 2016
Latent tuberculosis infection prevalence and risk of developing active TB among patients eligible for starting anti-TNFα therapy
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Prevalence of CNS lesions in patients with pulmonary tuberculosis and HIV infection
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019
Safety of the endobronchial valve use in the complex treatment of patients with destructive MDR/XDR TB associated with HIV infection.
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Immune diagnosis of tuberculosis in HIV
+
subjects with a clinical suspicion of active disease
Source: Eur Respir J 2004; 24: Suppl. 48, 427s
Year: 2004
Immune diagnosis of tuberculosis in HIV
+
subjects with a clinical suspicion of active disease
Source: Eur Respir J 2004; 24: Suppl. 48, 34s
Year: 2004
Does tuberculin skin test predict tuberculosis in end-stage liver disease
Source: Eur Respir J 2001; 18: Suppl. 33, 467s
Year: 2001
Quantiferon test in the complex diagnosis of tuberculosis in patients with end-stage kidney disease
Source: Virtual Congress 2020 – Tuberculosis and society
Year: 2020
COVID19 coinfection exacerbates lung inflammation in TB patients.
Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities
Year: 2021
Comparison of Quanti-FERON-TB Gold and tuberculin skin test for diagnosis of latent tuberculosis infection in patients with chronic schizophrenia
Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis?
Year: 2010
Prevalence and low diagnostics of chronic non-specific pulmonary diseases among pulmonary TB patients
Source: Annual Congress 2007 - Tuberculosis control in the penitentiary and civilian sector
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept